Imuldosa savings card: $0 a treatment with commercial insurance

How to pay the least

Ask for the cash price

Imuldosa

Imuldosa is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

Ask your pharmacy for Imuldosa’s cash price, and one or two other pharmacies too.
Imuldosa’s savings card works only with insurance from a job or one you bought.

Compare every option

Brand nameImuldosa

Authorized genericustekinumab-srlf

Regular genericustekinumab-srlf

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldAsk the pharmacy

Same as Imuldosa?

The original

–

Brand nameThe maker’s card

AccordCares Co-Pay Program

Savings card from Accord BioPharma

No insuranceNeeds insuranceNo cash price listed.

Insurance $0 a treatment

The card takes up to $6,000 a year off your co-pay.

In the maker’s words

“$0 co-pay per IMULDOSA treatment…”

From the maker’s offer on imuldosa.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Imuldosa itself, from the same company, sold without the brand name, and usually for less. For now Imuldosa is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Imuldosa is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

IMULDOSA is a human interleukin-12 and -23 antagonist indicated for the treatment of: Adult patients with:

moderate to severe plaque psoriasis in adults and pediatric patients 6 years of age and older who are candidates for phototherapy or systemic therapy.
active psoriatic arthritis in adult and pediatric patients 6 years of age and older.
moderately to severely active Crohn’s disease in adult patients.
moderately to severely active ulcerative colitis in adult patients.

Source: the FDA label for Imuldosa (Accord BioPharma Inc.), June 17, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/imuldosa/